Thursday, June 25, The European Medicines Agency has recommended authorizing the use of the anti-viral drug Remdesivir to treat the new Coronavirus. “Remdesivir is the first medicine against COVID-19 to be recommended for authorization in the EU,” the agency said. At least two major US studies have shown that Remdesivir can reduce the duration of hospital stays for COVID-19 patients. On average it reduced patients hospital stays from 15 days to 11.
Please submit your inquiry by completing the form. Your information will be kept strictly confidential.